BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15324694)

  • 1. Focus on bladder cancer.
    Dinney CP; McConkey DJ; Millikan RE; Wu X; Bar-Eli M; Adam L; Kamat AM; Siefker-Radtke AO; Tuziak T; Sabichi AL; Grossman HB; Benedict WF; Czerniak B
    Cancer Cell; 2004 Aug; 6(2):111-6. PubMed ID: 15324694
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of genetic alterations in normal bladder urothelium.
    Leonardo C; Gallucci M; Cianciulli AM
    Urology; 2004 Aug; 64(2):405; author reply 405-6. PubMed ID: 15302516
    [No Abstract]   [Full Text] [Related]  

  • 3. Tight junctions and bladder cancer (review).
    Haynes MD; Martin TA; Jenkins SA; Kynaston HG; Matthews PN; Jiang WG
    Int J Mol Med; 2005 Jul; 16(1):3-9. PubMed ID: 15942671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of oncoprotein E7 HPV16 in the cancer and normal urinary bladder urothelium].
    Volgareva GM; Zavalishina LE; Golovina DA; Andreeva IuIu; Ermilova VD; Cheban NL; Kuevda DA; Trofimova OB; Shipulina OIu; Pavlova LS; Petrov AN; Matveev VB; Shtil' AA; Frank GA
    Arkh Patol; 2009; 71(1):29-30. PubMed ID: 19514355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.
    Caprodossi S; Lucciarini R; Amantini C; Nabissi M; Canesin G; Ballarini P; Di Spilimbergo A; Cardarelli MA; Servi L; Mammana G; Santoni G
    Eur Urol; 2008 Sep; 54(3):612-20. PubMed ID: 17977643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior.
    Garcia-España A; Salazar E; Sun TT; Wu XR; Pellicer A
    Cancer Res; 2005 Feb; 65(4):1150-7. PubMed ID: 15734997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment by M-FISH of karyotypic complexity and cytogenetic evolution in bladder cancer in vitro.
    Ratliff TL
    J Urol; 2005 Nov; 174(5):2065. PubMed ID: 16217396
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment on: immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue.
    Papatsoris A; Deliveliotis C
    Eur Urol; 2008 May; 53(5):1073. PubMed ID: 17980953
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of TSC1/hamartin, 14-3-3sigma, and p27 expression with tumor outcomes in patients with pTa/pT1 urothelial bladder carcinoma.
    Mhawech-Fauceglia P; Alvarez V; Fischer G; Beck A; Herrmann FR
    Am J Clin Pathol; 2008 Jun; 129(6):918-23. PubMed ID: 18480009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of diagnostic and prognostic markers in urothelial carcinoma of the bladder.
    Coleman JF; Hansel DE
    Adv Anat Pathol; 2009 Mar; 16(2):67-78. PubMed ID: 19550368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis.
    Nakagawa T; Kanai Y; Ushijima S; Kitamura T; Kakizoe T; Hirohashi S
    J Urol; 2005 May; 173(5):1767-71. PubMed ID: 15821584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of variant histology on the outcome of bladder cancer treated with curative intent.
    Black PC; Brown GA; Dinney CP
    Urol Oncol; 2009; 27(1):3-7. PubMed ID: 18367107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative splicing of fibroblast growth factor receptor 3 produces a secreted isoform that inhibits fibroblast growth factor-induced proliferation and is repressed in urothelial carcinoma cell lines.
    Tomlinson DC; L'Hôte CG; Kennedy W; Pitt E; Knowles MA
    Cancer Res; 2005 Nov; 65(22):10441-9. PubMed ID: 16288035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non-invasive molecular detection of bladder cancer].
    Hatachmi S
    Harefuah; 2009 Jan; 148(1):66-9, 86. PubMed ID: 19320394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Schistosoma-associated bladder cancer differ from urothelial cancer? Proof from the laboratory and clinic.
    Zaghloul MS
    Cancer Genet Cytogenet; 2008 Jan; 180(2):160-2. PubMed ID: 18206545
    [No Abstract]   [Full Text] [Related]  

  • 16. Tbx3 expression is related to apoptosis and cell proliferation in rat bladder both hyperplastic epithelial cells and carcinoma cells.
    Ito A; Asamoto M; Hokaiwado N; Takahashi S; Shirai T
    Cancer Lett; 2005 Feb; 219(1):105-12. PubMed ID: 15694670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary bladder carcinogenesis induced by chronic exposure to persistent low-dose ionizing radiation after Chernobyl accident.
    Romanenko A; Kakehashi A; Morimura K; Wanibuchi H; Wei M; Vozianov A; Fukushima S
    Carcinogenesis; 2009 Nov; 30(11):1821-31. PubMed ID: 19643821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Unusual urinary bladder polyps].
    Petitjean B; Nagorniewicz F; Locquet P; Terrier-Lacombe MJ; Gaulard P
    Ann Pathol; 2002 Dec; 22(6):481-2. PubMed ID: 12594393
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavior of urothelial carcinoma with respect to anatomical location.
    Catto JW; Yates DR; Rehman I; Azzouzi AR; Patterson J; Sibony M; Cussenot O; Hamdy FC
    J Urol; 2007 May; 177(5):1715-20. PubMed ID: 17437794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.